Most Common Side Effects of Phosphodiesterase-5 Inhibitors
Headache is the most common side effect of PDE5 inhibitors (sildenafil/Viagra and Revatio), occurring in approximately 10-16% of patients, followed closely by flushing (5-16%), dyspepsia (3-11%), and nasal congestion.
Primary Side Effect Profile
The FDA-approved labeling for Revatio (sildenafil for pulmonary arterial hypertension) explicitly lists the most common side effects in adults as 1:
- Nosebleeds
- Headache
- Upset stomach (dyspepsia)
- Flushing (getting red or hot in the face)
- Arm or leg pain
- Muscle aches and pain
- Back pain
- Diarrhea
The 2018 AUA Guideline confirms this pattern across all PDE5 inhibitors, stating that the most frequently reported adverse events are dyspepsia, headache, flushing, back pain, nasal congestion, myalgia, visual disturbance, and dizziness 2. The 2025 European Association of Urology guidelines similarly acknowledge these adverse events across the PDE5 inhibitor class 3.
Comparative Frequency Data
Analysis of large-scale pharmacovigilance data from 31,827 individual case safety reports shows the following frequency distribution 4:
- Poor drug efficacy: 42.5% (reporting issue, not true adverse effect)
- Headache: 10.4% (vs. 8.5-27.6% in FDA trials)
- Abnormal vision: 8.4% (vs. ≤4.6% in FDA trials)
- Flushing: 5.2% (vs. 5.1-16.5% in FDA trials)
- Dyspepsia: 4.2% (vs. 3.4-11.1% in FDA trials)
Mechanism and Clinical Significance
These side effects result from the mild vasodilatory effects of PDE5 inhibition beyond the target tissue 5. The adverse events are generally dose-dependent, reversible, and tend to diminish with continued treatment 5. Importantly, discontinuation rates due to adverse events remain low at <2-3% across all PDE5 inhibitors 2, 6.
Minor Differences Between Agents
While the overall side effect profile is similar across all PDE5 inhibitors, subtle differences exist 2:
- Dyspepsia: Lowest with avanafil
- Flushing: Lowest with tadalafil
- Myalgia: Lowest with vardenafil and avanafil
Critical Safety Considerations
Beyond common side effects, clinicians must counsel patients about serious but rare adverse events 1:
- Vision changes (NAION - non-arteritic anterior ischemic optic neuropathy)
- Sudden hearing loss with or without tinnitus
- Priapism (erection >4 hours) - particularly important in children on Revatio
- Hypotension - especially when combined with antihypertensives
The combination of PDE5 inhibitors with nitrates is absolutely contraindicated due to synergistic vasodilation that can cause life-threatening hypotension 1, 6.
Clinical Pitfall
The most common clinical error is inadequate patient education about proper dosing and timing, which can lead to perceived treatment failure rather than true adverse effects 2. Patients should be instructed that sexual stimulation is required for efficacy, and timing of administration varies by agent (sildenafil/vardenafil: ~4 hours; tadalafil: up to 36 hours) 5.